Popular diabetes drug ‘Ozempic’ may no longer be subsidized as the Danish Medicines Agency assesses whether this could save millions of kroner in health subsidies. Known...
We use essential cookies to make the site work.
The newsletter signup form (powered by Substack) is always enabled and may load content from Substack.
You can choose whether to allow analytics/marketing cookies.
Read our policy